ABBV
Price
$194.19
Change
-$0.16 (-0.08%)
Updated
Oct 11 closing price
18 days until earnings call
BMY
Price
$52.20
Change
-$0.20 (-0.38%)
Updated
Oct 11 closing price
19 days until earnings call
Ad is loading...

ABBV vs BMY

Header iconABBV vs BMY Comparison
Open Charts ABBV vs BMYBanner chart's image
ABBVIE
Price$194.19
Change-$0.16 (-0.08%)
Volume$2.97M
CapitalizationN/A
Bristol-Myers Squibb
Price$52.20
Change-$0.20 (-0.38%)
Volume$6.04M
CapitalizationN/A
View a ticker or compare two or three
ABBV vs BMY Comparison Chart
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BMY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABBV vs. BMY commentary
Oct 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a StrongSell and BMY is a Buy.

COMPARISON
Comparison
Oct 12, 2024
Stock price -- (ABBV: $194.19 vs. BMY: $52.20)
Brand notoriety: ABBV and BMY are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 69% vs. BMY: 54%
Market capitalization -- ABBV: $322.43B vs. BMY: $109.66B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. BMY’s [@Pharmaceuticals: Major] market capitalization is $109.66B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 4 FA rating(s) are green whileBMY’s FA Score has 1 green FA rating(s).

  • ABBV’s FA Score: 4 green, 1 red.
  • BMY’s FA Score: 1 green, 4 red.
According to our system of comparison, ABBV is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 2 TA indicator(s) are bullish while BMY’s TA Score has 5 bullish TA indicator(s).

  • ABBV’s TA Score: 2 bullish, 6 bearish.
  • BMY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BMY is a better buy in the short-term than ABBV.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а -0.05% price change this week, while BMY (@Pharmaceuticals: Major) price change was -3.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.02%. For the same industry, the average monthly price growth was -0.06%, and the average quarterly price growth was +8.84%.

Reported Earning Dates

ABBV is expected to report earnings on Jan 29, 2025.

BMY is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABBV($322B) has a higher market cap than BMY($110B). ABBV has higher P/E ratio than BMY: ABBV (66.46) vs BMY (13.73). ABBV YTD gains are higher at: 28.860 vs. BMY (6.879). BMY has higher annual earnings (EBITDA): 19.4B vs. ABBV (17.2B). ABBV (12.8B) and BMY (12.3B) have equal amount of cash in the bank . BMY has less debt than ABBV: BMY (41.5B) vs ABBV (59.4B). ABBV has higher revenues than BMY: ABBV (54.3B) vs BMY (45B).
ABBVBMYABBV / BMY
Capitalization322B110B293%
EBITDA17.2B19.4B89%
Gain YTD28.8606.879420%
P/E Ratio66.4613.73484%
Revenue54.3B45B121%
Total Cash12.8B12.3B104%
Total Debt59.4B41.5B143%
FUNDAMENTALS RATINGS
ABBV vs BMY: Fundamental Ratings
ABBV
BMY
OUTLOOK RATING
1..100
5522
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
368
SMR RATING
1..100
1995
PRICE GROWTH RATING
1..100
4544
P/E GROWTH RATING
1..100
1192
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (7) in the Pharmaceuticals Major industry is in the same range as ABBV (21). This means that BMY’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's Profit vs Risk Rating (3) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMY (68). This means that ABBV’s stock grew somewhat faster than BMY’s over the last 12 months.

ABBV's SMR Rating (19) in the Pharmaceuticals Major industry is significantly better than the same rating for BMY (95). This means that ABBV’s stock grew significantly faster than BMY’s over the last 12 months.

BMY's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as ABBV (45). This means that BMY’s stock grew similarly to ABBV’s over the last 12 months.

ABBV's P/E Growth Rating (11) in the Pharmaceuticals Major industry is significantly better than the same rating for BMY (92). This means that ABBV’s stock grew significantly faster than BMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVBMY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
45%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
51%
Momentum
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
57%
MACD
ODDS (%)
Bearish Trend 2 days ago
39%
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
49%
Bearish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 13 days ago
59%
Bullish Trend 9 days ago
55%
Declines
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
39%
Bearish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
57%
View a ticker or compare two or three
Ad is loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BMY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X62445.0900002170.586000
+3.60%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with JNJ. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
-0.38%
JNJ - BMY
48%
Loosely correlated
+0.59%
GILD - BMY
36%
Loosely correlated
+0.33%
PFE - BMY
36%
Loosely correlated
-0.61%
ABBV - BMY
34%
Loosely correlated
-0.08%
RHHBY - BMY
30%
Poorly correlated
+0.80%
More